from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3712/-

LFCtreatmentdescriptionclass of inhibitor

-1.102

Amikacinug/mL Amikacintranslation

0.045

Cap5-10ug/mL Capreomycintranslation

-0.056

Rox10-50 ug/mL Roxithromycintranslation

0.690

SM2-5 ug/mL Streptomycintranslation

-0.747

Tet5-10 ug/mL Tetracyclinetranslation

-0.223

Rif0.2-5ug/mL Rifampicintranscription

-0.373

Rifp0.1-0.5ug/mL Rifapentinetranscription

4.851

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.720

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.889

CPZ10-50 ug/mL Chlorpromazinerespiration

0.354

Clofazimine10-13 ug/mL Clofaziminerespiration

0.145

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.351

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.730

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.051

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.283

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.958

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.588

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-2.448

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.361

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.493

KCN5-20 ug/mL Potassium cyaniderespiration

2.163

NaN30.2-2 mM Sodium aziderespiration

-0.099

Nigericin50 uM Nigericinrespiration

0.288

TRC10-150 ug/mL Triclosanrespiration

-0.369

TRZ10-25 ug/mL Thioridazinerespiration

-0.241

Valinomycin0.5-10 uM Valinomycinrespiration

-0.475

ZnSO42 mM ZnSO4respiration

-0.310

menadione6-10 ug/mL Menadionerespiration

0.133

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.621

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.120

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.584

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.043

NRP_1Non-replicating persistence stage 1dosRassociated

0.698

Amp0.2mg/mL AmpicillincellWall

0.132

Cephalexin20-100 ug/mL CephalexincellWall

0.416

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.285

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.092

EMB10-20 ug/mL EthambutolcellWall

1.029

Eta12-40 ug/mL EthionamidecellWall

1.112

INH0.2-0.4 ug/mL IsoniazidcellWall

0.475

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.393

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.354

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.072

BZA0.12 mg/mL BenzamidearomaticAmides

-0.345

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.069

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.172

H2O24 mM hydrogen peroxideDNAdamaging

0.537

Levo10 ug/mL LevofloxacinDNAdamaging

0.017

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.290

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.219

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.272

UVUV-irradiationDNAdamaging

-0.202

ARP41-4 ug/mL Antitubercular compound ARP4?

0.006

Antimycin12.5-50 ug/mL Antimycin A?

0.432

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.642

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.823

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.550

PA8240.2-2 ug/mL PA-824?

-0.431

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.182

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.137

Verapamil50 uM Verapamil?

0.031

mercaptoethanol2 mM 2-Mercaptoethanol?

0.671

methoxatin10-20 ug/mL Methoxatin?